Results 211 to 220 of about 9,451,716 (342)

Adherence to Surgical Antimicrobial Prophylaxis Guidelines and Improvement Efforts: A Single-Center, Pre- and Post-Intervention Comparison Study. [PDF]

Health Sci Rep
Yamamoto C, Nukui Y, Kosaka T, Aoto K, Kozen R, Hasegawa K, Ota C, Inoue Y, Taniguchi M, Hamashima R, Furukawa K, Kikuchi K, Nakanishi A, Teramukai S, Horii Y, Sawa T.   +15 more
europepmc   +1 more source

Insulin Administration [PDF]

Diabetes Care, 2001
openaire   +2 more sources

Preclinical pharmacokinetics and tissue distribution of a polyhexamethylene guanidine derivative after ocular mucosal administration [PDF]

И. С. Иванов, Д. О. Шаталов, Daria Kirillova, Danila A. Petrusevich, С. В. Беляков, С. А. Кедик   +5 more
openalex   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

Future Administrators [PDF]

Science, 1965
openaire   +2 more sources

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

The efficacy and safety of lower-dose aspirin for primary and secondary prevention of cardiovascular disease in the elderly: an interim analysis of a multicenter, prospective, observational study. [PDF]

Front Cardiovasc Med
Wang X, Qi H, Wu Y, Cong H, Hao P, Liu X, Liu Y, Yao Z, Jin A, Hou Y, He N, Zhao Y, Sun Y, Qian X, Liang K, Zhang H, Liu L, Zhang Z, Liu Y, Dou P, Xia S, Li H, Yang J, Hu J, Xia Z, Liu B, Jin H, Yan X, Miao W, Guo H, Zhao L, Zhang Q, Tian T, Sun X, He J, Chen X, Wang Z, Zhang Z, Liu Q, Wang J, Zhu S, Liu M.   +41 more
europepmc   +1 more source

Insulin Administration [PDF]

Diabetes Care, 2004
openaire   +2 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Temporal dynamics of mesenchymal stem cell administration influence immune modulation in a 4T1 breast cancer model. [PDF]

Cell Transplant
Papic D, Pavlovic D, Niciforovic D, Jurisic V, Volarevic V.   +4 more
europepmc   +1 more source